HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Primary Peritoneal Cancer

Primary peritoneal cancer is a rare and aggressive form of cancer that develops in the peritoneum, the thin layer of tissue lining the abdomen and covering the organs within it. This type of cancer is closely related to epithelial ovarian cancer and often presents with similar symptoms. The peritoneum plays a crucial role in supporting and protecting abdominal organs, and when cancer originates in this tissue, it can rapidly spread to neighboring organs and tissues. The exact cause of primary peritoneal cancer is not well understood, but it is believed to be linked to genetic factors and mutations. Symptoms of primary peritoneal cancer may include abdominal pain or discomfort, bloating, changes in bowel habits, and unexplained weight loss. However, these symptoms are non-specific and can be associated with various other conditions, making early detection challenging. Diagnosis typically involves a combination of imaging tests, such as CT scans and ultrasounds, along with biopsies to confirm the presence of cancer cells. Treatment options often include a combination of surgery, chemotherapy, and sometimes radiation therapy. Due to the aggressive nature of primary peritoneal cancer, a multidisciplinary approach involving oncologists, surgeons, and other healthcare professionals is crucial in managing the disease. Prognosis for primary peritoneal cancer varies, and it depends on factors such as the stage at which the cancer is diagnosed and the individual's overall health. Early detection and prompt intervention can significantly improve outcomes, but the disease is often diagnosed in advanced stages, making successful treatment more challenging. Supportive care, including palliative measures to manage symptoms and enhance the quality of life, is an essential aspect of primary peritoneal cancer management. Patients and their families benefit from a comprehensive support system, including counseling, pain management, and resources for coping with the emotional and physical challenges associated with the disease.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp